Galena Biopharma (GALE) Sells Abstral Tablet in $12M Deal
Tweet Send to a Friend
Galena Biopharma (NASDAQ: GALE) announced the sale of its Abstral (fentanyl) Sublingual Tablet product to a private company in a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE